TICKERNOMICS Sign up
Last Update: 2024-03-28 02:14:05
Oncology Institute Inc. ( TOI ) https://theoncologyinstitute.com
1.69USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
TOI
156.25%
SPY
32.74%
TOI
0.00%
SPY
92.93%
TOI
0.00%
SPY
224.41%
TOI
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
114.61
178.16
0.16
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.55
0.37
1.60
-36.54
0.00
-3.37
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-16.97
19.48
-16.47
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-34.83
-26.53
0.00
Other Earnings and Cash Flow Stats:
Oncology Institute Inc. ( TOI ) Net Income TTM ($MM) is -59.59
Oncology Institute Inc. ( TOI ) Operating Income TTM ($MM) is -65.16
Oncology Institute Inc. ( TOI ) Owners' Earnings Annual ($MM) is 0.00
Oncology Institute Inc. ( TOI ) Current Price to Owners' Earnings ratio is 0.00
Oncology Institute Inc. ( TOI ) EBITDA TTM ($MM) is -59.23
Oncology Institute Inc. ( TOI ) EBITDA Margin is -16.47%
Capital Allocation:
Oncology Institute Inc. ( TOI ) has paid 0.00 dividends per share and bought back 7.136499 million shares in the past 12 months
Oncology Institute Inc. ( TOI ) has increased its debt by 9.749 million USD in the last 12 months
Capital Structure:
Oncology Institute Inc. ( TOI ) Interest-bearing Debt ($MM) as of last quarter is 123
Oncology Institute Inc. ( TOI ) Annual Working Capital Investments ($MM) are -33
Oncology Institute Inc. ( TOI ) Book Value ($MM) as of last quarter is 71
Oncology Institute Inc. ( TOI ) Debt/Capital as of last quarter is 171%
Other Balance Sheet Stats:
Oncology Institute Inc. ( TOI ) has 27 million in cash on hand as of last quarter
Oncology Institute Inc. ( TOI ) has 32 million of liabilities due within 12 months, and long term debt 85 as of last quarter
Oncology Institute Inc. ( TOI ) has 73 common shares outstanding as of last quarter
Oncology Institute Inc. ( TOI ) has 0 million USD of preferred stock value
Academic Scores:
Oncology Institute Inc. ( TOI ) Altman Z-Score is 0.89 as of last quarter
Oncology Institute Inc. ( TOI ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
Oncology Institute Inc. ( TOI ) largest shareholder is BlackRock Inc owning 237846 shares at 0.40 ($MM) value
Havencrest Healthcare Partners(an insider) Sold 8637 shares of Oncology Institute Inc. ( TOI ) for the amount of $18310.44 on 2024-01-29
19.02% of Oncology Institute Inc. ( TOI ) is held by insiders, and 58.29% is held by institutions
Oncology Institute Inc. ( TOI ) went public on 2021-11-15
Other Oncology Institute Inc. ( TOI ) financial metrics:
FCF:-64.11
Unlevered Free Cash Flow:-23.77
EPS:-0.95
Operating Margin:-16.97
Gross Profit Margin:19.48
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-96.98
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Oncology Institute Inc. ( TOI ) :
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.